13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-14, with 64 holding rows worth $2,431,061,000.
- Accession
- 0001104659-14-038454
- Filer
- CIK 1274413
- Filed
- 2014-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 64 entries on the cover page, a total value of $2,431,061,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,431,061,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Amgen Inc. | 031162100 | COM | 1,405,062 | $173,300,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 536,393 | $164,067,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 2,057,416 | $145,788,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 785,500 | $94,449,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 307,400 | $92,306,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 1,276,741 | $90,291,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 548,008 | $83,368,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 566,236 | $79,047,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,441,992 | $76,195,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 1,403,160 | $75,097,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 5,355,488 | $68,041,000 | thousands by filing date | |
| MYLAN INC | 628530107 | COM | 1,390,697 | $67,908,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 927,406 | $63,258,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 496,548 | $61,622,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 293,950 | $60,510,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 3,537,590 | $60,281,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 391,197 | $58,104,000 | thousands by filing date | |
| THERAVANCE INC | 88338T104 | COMMON STOCK | 1,851,088 | $57,273,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,642,182 | $57,192,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 3,623,786 | $54,103,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,347,642 | $45,348,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 934,100 | $43,137,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 1,408,729 | $42,163,000 | thousands by filing date | |
| SYNAGEVA BIOPHARMA CORP | 87159A103 | COM | 465,145 | $38,593,000 | thousands by filing date | |
| ISIS PHARMACEUTICALS INC | 464330109 | COM | 882,101 | $38,116,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 667,537 | $37,896,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 244,989 | $36,420,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 493,400 | $34,178,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 1,212,245 | $31,397,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 452,764 | $28,710,000 | thousands by filing date | |
| FOREST LABS INC | 345838106 | COM | 270,100 | $24,922,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 1,408,908 | $24,895,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 947,902 | $24,778,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 74,493 | $24,567,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 1,038,504 | $24,270,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,172,121 | $22,317,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 234,400 | $22,041,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 442,819 | $20,175,000 | thousands by filing date | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 431,612 | $18,948,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 128,800 | $16,980,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 761,443 | $16,752,000 | thousands by filing date | |
| COVIDIEN PLC | G2554F113 | SHS | 209,876 | $15,459,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 32,408 | $14,194,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 273,979 | $14,083,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,019,221 | $13,780,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,110,797 | $12,941,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 197,072 | $10,206,000 | thousands by filing date | |
| TORNIER NV | N87237108 | COMMON STOCK-FO | 442,801 | $9,396,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 99,241 | $9,307,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 496,465 | $6,325,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 136,610 | $6,236,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 283,410 | $4,679,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 483,739 | $4,644,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 71,346 | $2,951,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 31,200 | $2,653,000 | thousands by filing date | |
| SESEN BIO, INC. | 286221106 | COM | 50,000 | $812,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 221,462 | $742,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 44,587 | $728,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 30,100 | $665,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 32,372 | $636,000 | thousands by filing date | |
| LPATH INC-CLASS A | 548910306 | CMN | 126,464 | $601,000 | thousands by filing date | |
| TEKMIRA PHARMACEUTICALS COR | 87911B209 | COM NEW | 27,500 | $591,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 30,000 | $382,000 | thousands by filing date | |
| WUXI PHARMATECH CAYMAN INC | 929352102 | SPONS ADR SHS | 6,690 | $247,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-14-038454 | this filing | 2014-05-14 | acceptance time not in the bulk data set |